Similar to NNMT knockdown, the combination of NNMT inhibitor and EGFR-TKI treatment significantly overcame EGFR-TKI resistance and showed a significant synergistic effect in inhibition of EGFR-TKI resistant NSCLC cells. Here, EGFR is linked to non-small cell lung carcinoma.